Zhejiang Hisun Pharmaceutical Co., Ltd.SSE: 600267

Announcement on Estimated Daily Related Party Transactions in 2026

· Issued by Zhejiang Hisun Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 8 pages · Chinese

Summary by 6ix AI

Zhejiang Hisun Pharmaceutical Co., Ltd. has announced its estimated daily related party transactions for the upcoming year. The board has approved these transactions, which do not require shareholder approval as they do not exceed specified thresholds. The filing outlines the nature of these transactions, including procurement of materials and rental agreements with related parties. It emphasizes that these transactions are necessary for the company's operations and are conducted at market prices, ensuring no adverse impact on the company's independence or financial health.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Estimated Daily Related Party Transactions in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Hisun Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Hisun Pharmaceutical

Later from Zhejiang Hisun Pharmaceutical

All Zhejiang Hisun Pharmaceutical news releases